Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49310 | 0.74 | — | — | |
| SCHEMBL4521012 | 0.70 | MAPK1 (0.56) | MAPK1ALDH1A1TSHRALOX15 | |
| SCHEMBL4169444 | 0.70 | MAPK1 (0.44) | MAPK1ALDH1A1TSHRALOX15 | |
| SCHEMBL3121099 | 0.68 | MAPK1 (0.43) | MAPK1ALDH1A1TSHRALOX15 | |
| Ethane SCHEMBL4422248 | 0.68 | TSHR (0.41) | TDP1ALDH1A1TSHR | |
| Ethane SCHEMBL4423645 | 0.68 | — | — | |
| SCHEMBL8671671 | 0.68 | — | — | |
| SCHEMBL49436 | 0.68 | — | — | |
| Benzene SCHEMBL28128746 | 0.68 | ALDH1A1 (0.43) | MAPK1TDP1ALDH1A1TSHRALOX15 | |
| Vinyl Ether SCHEMBL27859262 | 0.66 | TDP1 (0.38) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100063302-A1 | CYCLIC SULFONIUM SALT, METHOD FOR PRODUCTION OF CYCLIC SULFONIUM SALT, AND GLYCOSIDASE INHIBITOR | TAKANO CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063302-A1 | CYCLIC SULFONIUM SALT, METHOD FOR PRODUCTION OF CYCLIC SULFONIUM SALT, AND GLYCOSIDASE INHIBITOR | STS, SI, DDOST | MAPK1 534/4885TDP1 899/4885ALDH1A1 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.